Novel GLP-Grade E-Selectin/AAV2 Gene Therapy Optimal Dosage for Vascular Regeneration
Saved in:
Main Authors: | Francesca A. Voza, Yulexi Ortiz, Nga Le, Antoine Ribieras, Zhao-Jun Liu, Omaida Caridad Velazquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | JVS - Vascular Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666350324000646 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model
by: Antoine J. Ribieras, et al.
Published: (2023-01-01) -
AAV-regulated Serpine2 overexpression promotes hair cell regeneration
by: Qiuhan Sun, et al.
Published: (2024-12-01) -
P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation
by: Viorel Simion, et al.
Published: (2016-01-01) -
Correction to “AAV‐Mediated Gene Cocktails Enhance Supporting Cell Reprogramming and Hair Cell Regeneration”
by: Liyan Zhang, et al.
Published: (2025-02-01) -
Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD
by: Monika Rac, et al.
Published: (2024-12-01)